CWM
CDTX

CIBC World Markets’s Cidara Therapeutics CDTX Stock Holding History

CIBC World Markets’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$286K Buy
+1,297
New +$210K ﹤0.01% 973

Other funds holding CDTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

CIBC World Markets's CDTX Position: Q4 2025 in Review

CIBC World Markets opened a new position in Cidara Therapeutics (CDTX) in Q4 2025: 1,297 shares worth $286K. The stake represents ﹤0.01% of the portfolio and ranks #973 among its holdings.

255 funds tracked by Wall St. Rank hold CDTX as of Q4 2025.

  • CIBC World Markets held 1,297 shares of Cidara Therapeutics worth $286K as of Q4 2025.
  • Cidara Therapeutics was a new CIBC World Markets position in Q4 2025.
  • Cidara Therapeutics made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #973 holding.
  • 255 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.